Evaluation of endometrial carcinoma on magnetic resonance imaging

International Journal of Gynecological Cancer

Volumn 17, Issue 1, 2007, Pages 188-196

  Rockall, A G ^a   Meroni, R ^a   Sohaib, S A ^b   Reynolds, K ^a   Alexander Sefre, F ^a   Shepherd, J H ^a   Jacobs, I ^c   Reznek, R H ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Endometrial carcinoma; Lymph node metastases; MRI

Indexed keywords

GADOLINIUM;

ADENOMYOSIS; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY; TUMOR VOLUME; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERUS MYOMA;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM INVASIVENESS; REPRODUCIBILITY OF RESULTS;

EID: 33846806011     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00805.x     Document Type: Article

References (38)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Toms JR, ed. CancerStats monograph 2004. London, UK: Cancer Research UK, 2004.
3. Berman ML, Ballon SC, Lagasse LD, Watring WG. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 1980;136:679-88.
4. Palter SF, Olive DL. Uterine cancer. In: Berek JS, ed. Novak's gynecology. Baltimore, MD: Williams & Wilkins, 1996:1057-85.
5. Lee EJ, Byun JY, Kim BS, Koong SE, Shinn KS. Staging of early endometrial carcinoma: assessment with T2-weighted and gadolinium-enhanced T1-weighted MR imaging. Radiographics 1999;19:937-45.
6. Ascher SM, Takahama J, Jha RC. Staging of gynecologic malignancies. Top Magn Reson Imaging 2001;12:105-29.
7. McMeekin DS, Lashbrook D, Gold M et al. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 2001;82:375-9.
8. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
9. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996;88:394-8.
10. Frei KA, Kinkel K. Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 2001;13:850-5.
11. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer 1987;60(Suppl. 8):2035-41.
12. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 1991;40:55-65.
13. Tozzi R, Malur S, Koehler C, Schneider A. Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy?. Gynecol Oncol 2005;97:4-9.
14. Partridge EE, Shingleton HM, Menck HR. The National Cancer Data Base report on endometrial cancer. J Surg Oncol 1996;61:111-23.
15. Kitchner H, Redman CW, Swart AW, Amos CL. A study in the treatment of endometrial carcinoma: a randomised trial of lymphadenectomy in the treatment of endometrial carcinoma. Gynecol Oncol 2006;101(Supp):21-22.
16. Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H. Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 1993;186:495-501.
17. Joja I, Asakawa M, Asakawa T et al. Endometrial carcinoma: dynamic MRI with turbo-FLASH technique. J Comput Assist Tomogr 1996;20:878-87.
18. Savci G, Ozyaman T, Tutar M, Bilgin T, Erol O, Tuncel E. Assessment of depth of myometrial invasion by endometrial carcinoma: comparison of T2-weighted SE and contrast-enhanced dynamic GRE MR imaging. Eur Radiol 1998;8:218-23.
19. Rockall AG, Sohaib SA, Harisinghani MG et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005;23:2813-21.
20. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 1991;179:829-32.
21. Kamura T, Yahata H, Shigematsu T et al. Predicting pelvic lymph node metastasis in endometrial carcinoma. Gynecol Oncol 1999;72:387-91.
22. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 1989;96:889-92.
23. Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler ML, Lacey CG. Endometrial carcinoma staging by MR imaging. Radiology 1987;162:297-305.
24. Lien HH, Blomlie V, Trope C, Kaern J, Abeler VM. Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium. AJR Am J Roentgenol 1991;157:1221-3.
25. Sironi S, Colombo E, Villa G et al. Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 1992;185:207-12.
26. Hricak H, Hamm B, Semelka RC et al. Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging. Radiology 1991;181:95-106.
27. Manfredi R, Mirk P, Maresca G et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 2004;231:372-78.
28. Yamashita Y, Mizutani H, Torashima M et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR Am J Roentgenol 1993;161:595-99.
29. Seki H, Kimura M, Sakai K. Myometrial invasion of endometrial carcinoma: assessment with dynamic MR and contrast-enhanced T1-weighted images. Clin Radiol 1997;52:18-23.
30. Toki T, Oka K, Nakayama K, Oguchi O, Fujii S. A comparative study of pre-operative procedures to assess cervical invasion by endometrial carcinoma. Br J Obstet Gynaecol 1998;105:512-6.
31. Nagar H, Dobbs S, McClelland HR, Price J, McCluggage WG, Grey A. The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. Gynecol Oncol 2006;103(2):431- 4.
32. Creasman WT, DeGeest K, Disaia PJ, Zaino RJ. Significance of true surgical pathologic staging: a gynecologic oncology group study. Am J Obstet Gynecol 1999;181:31-4.
33. Nakamoto Y, Saga T, Jujji S. Positron emission tomography application for gynecologic tumors. Int J Gynecol Cancer 2005;15(5):701-9.
34. Trattner M, Graf AH, Lax S et al. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol 2001;82:11-6.
35. Kim SH, Kim HD, Song YS, Kang SB, Lee HP. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr 1995;19:766-72.
36. Cagnazzo G, D'Addario V, Martinelli G, Lastilla G. Depth of myometrial invasion in endometrial cancer: preoperative assessment by transvaginal ultrasonography and magnetic resonance imaging. Ultrasound Obstet Gynecol 1992;2:40-3.
37. DelMaschio A, Vanzulli A, Sironi S et al. Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. AJR Am J Roentgenol 1993;160:533-8.
38. Zarbo G, Caruso G, Caruso S, Mangano U, Zarbo R. Endometrial cancer: preoperative evaluation of myometrial infiltration magnetic resonance imaging versus transvaginal ultrasonography. Eur J Gynaecol Oncol 2000;21:95-7.